RASP (RASP) Stock Price & Analysis
RASP (RASP) rose 0.00% to USD 0 as of June 10, 2026 at 04:35 UTC, according to Nexqual real-time market data.
RASP last closed at USD 0; the session ranged USD 0–0 on volume of 20 shares. Market capitalization is $385,905, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 04:35 UTC.
Key Statistics (as of June 10, 2026 at 04:35 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 20 shares |
| Market Cap | $385,905 |
| Exchange | PNK |
Technical Analysis (RASP)
Nexqual's technical model rates RASP "BUY" based on 4 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 04:35 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (RASP)
Wall Street analysts rate RASP "None", per Nexqual as of June 10, 2026 at 04:35 UTC.
| Consensus Rating | None |
|---|
Earnings (RASP)
Source: Nexqual, June 10, 2026 at 04:35 UTC.
Financials & Fundamentals (RASP)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
Source: Nexqual, June 10, 2026 at 04:35 UTC.
Financial Health Score (RASP)
Nexqual rates RASP's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 04:35 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Ownership (RASP)
| Insider Ownership | +85.19% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 771.81M |
Source: Nexqual, June 10, 2026 at 04:35 UTC.
Leadership (RASP)
RASP is led by Keeren Shah (age 49), Chief Financial Officer, per Nexqual as of June 10, 2026 at 04:35 UTC.
| Chief Financial Officer | Keeren Shah (age 49) |
|---|---|
| Executive Chairman | Willy Jules Simon (age 74) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| KNBIF | Kane Biotech Inc. | USD 0.03 | ▲ 14.68% |
| NBIO | Nascent Biotech Inc. | USD 0 | ▲ 0% |
| EESE | Energy & Environmental Services | USD 0.09 | ▲ 0% |
| SRBCF | Sirona Biochem Corp. | USD 0.01 | ▲ 0% |
| CLCS | Cell Source, Inc. | USD 0.82 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 04:35 UTC. This page is informational and not investment advice.